Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Psoriasis, Date of authorisation: 17/09/2018, Revision: 10, Status: Authorised
Non-Clinical and New Approach Methodologies European Specialised Expert Community
Mandate, objective and rules of procedure for the Non-Clinical and New Approach Methodologies European Specialised Expert Community
Revocation of authorisation for sickle cell disease medicine Adakveo
Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Diabetes Mellitus, Date of authorisation: 09/06/2000, Revision: 40, Status: Authorised
Withdrawn application: Lagevrio, molnupiravir, Date of withdrawal: 21/06/2023, Initial authorisation
Methotrexate supply shortage
Informed consent for paediatric clinical trials in Europe 2015
List of eligible industry stakeholder organisations
Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Hematopoietic Stem Cell Transplantation, Date of authorisation: 20/06/2019, Revision: 4, Status: Authorised